These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


281 related items for PubMed ID: 4771353

  • 1. [The present status of fibrinolytic therapy].
    Koller F.
    Bull Schweiz Akad Med Wiss; 1973 Nov; 29(4):263-75. PubMed ID: 4771353
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Fibrinolytic guidelines in diabetes.
    Sharma GV, Mukerjee DK, Sasahara AA.
    Geriatrics; 1982 Apr; 37(4):38-42, 46. PubMed ID: 7060947
    [Abstract] [Full Text] [Related]

  • 4. [Indications of anticoagulant and fibrinolytic drugs in the prevention and therapy of thromboembolic diseases].
    Verstraete M.
    Clin Ter; 1975 Jun 15; 73(5):403-22. PubMed ID: 1139864
    [No Abstract] [Full Text] [Related]

  • 5. Thrombolytic therapy.
    Duckert F.
    Semin Thromb Hemost; 1984 Jan 15; 10(1):87-103. PubMed ID: 6701539
    [No Abstract] [Full Text] [Related]

  • 6. Fibrinolytic therapy.
    Persson AV, Padberg FT, Dyer VE.
    Compr Ther; 1980 Nov 15; 6(11):12-7. PubMed ID: 7438726
    [Abstract] [Full Text] [Related]

  • 7. [Thrombolytic therapy with a standardized system of dosage of purified streptokinase].
    Verstraete M, Vermylen J, Tytgat G.
    Acta Chir Belg; 1966 Oct 15; 65(7):745-58. PubMed ID: 5972544
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Thrombolytic therapy: current status (2).
    Marder VJ, Sherry S.
    N Engl J Med; 1988 Jun 16; 318(24):1585-95. PubMed ID: 3287158
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Thrombolytic therapy].
    Schimpf K.
    Dtsch Med Wochenschr; 1969 Oct 31; 94(44):2292-4. PubMed ID: 5350098
    [No Abstract] [Full Text] [Related]

  • 12. Protracted use of dicoumarol anticoagulants in the treatment of peripheral arteriopathies.
    Raso AM, Roviera C, Scevola G.
    Panminerva Med; 1975 Oct 31; 16(7-8):238-45. PubMed ID: 45868
    [No Abstract] [Full Text] [Related]

  • 13. The present place of fibrinolytic therapy.
    Sharp AA.
    Ann R Coll Surg Engl; 1971 Jan 31; 48(1):27-8. PubMed ID: 5572220
    [No Abstract] [Full Text] [Related]

  • 14. New approach to thrombolytic therapy: the use of Defibrase in connection with streptokinase.
    Latallo ZS, Lopaciuk S.
    Thromb Diath Haemorrh Suppl; 1973 Jan 31; 56():253-64. PubMed ID: 4617332
    [No Abstract] [Full Text] [Related]

  • 15. [Medical treatment of deep vein leg thrombosis with medications other than heparin].
    Samama M, Hodara M, Kher A.
    Therapie; 1978 Jan 31; 33(1):55-73. PubMed ID: 351852
    [No Abstract] [Full Text] [Related]

  • 16. Thrombolytic therapy--a new realistic approach in treatment of thromboocclusive vascular disease.
    Bell WR.
    Surgery; 1982 Nov 31; 92(5):913-4. PubMed ID: 7135213
    [No Abstract] [Full Text] [Related]

  • 17. [Clinical aspects of thrombolytic therapy].
    Schmutzler R.
    Internist (Berl); 1969 Jan 31; 10(1):21-9. PubMed ID: 4906437
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Current status of fibrnnolytic medication].
    Perrin MA.
    Rev Lyon Med; 1968 Jun 30; 17(12):543-6. PubMed ID: 5759689
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 15.